Wadasadawala Tabassum, Joshi Shalaka, Rath Sushmita, Popat Palak, Sahay Ayushi, Gulia Seema, Bhargava Prabhat, Krishnamurthy Revathy, Hoysal Dileep, Shah Jessicka, Engineer Mitchelle, Bajpai Jyoti, Kothari Bhavika, Pathak Rima, Jaiswal Dushyant, Desai Sangeeta, Shet Tanuja, Patil Asawari, Pai Trupti, Haria Purvi, Katdare Aparna, Chauhan Sonal, Siddique Shabina, Vanmali Vaibhav, Hawaldar Rohini, Gupta Sudeep, Sarin Rajiv, Badwe Rajendra
Department of Radiation Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
Department of Surgical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
Indian J Cancer. 2024 Jan 1;61(Suppl 1):S52-S79. doi: 10.4103/ijc.ijc_55_24. Epub 2024 Mar 1.
The incidence of breast cancer is increasing rapidly in urban India due to the changing lifestyle and exposure to risk factors. Diagnosis at an advanced stage and in younger women are the most concerning issues of breast cancer in India. Lack of awareness and social taboos related to cancer diagnosis make women feel hesitant to seek timely medical advice. As almost half of women develop breast cancer at an age younger than 50 years, breast cancer diagnosis poses a huge financial burden on the household and impacts the entire family. Moreover, inaccessibility, unaffordability, and high out-of-pocket expenditure make this situation grimmer. Women find it difficult to get quality cancer care closer to their homes and end up traveling long distances for seeking treatment. Significant differences in the cancer epidemiology compared to the west make the adoption of western breast cancer management guidelines challenging for Indian women. In this article, we intend to provide a comprehensive review of the management of breast cancer from diagnosis to treatment for both early and advanced stages from the perspective of low-middle-income countries. Starting with a brief introduction to epidemiology and guidelines for diagnostic modalities (imaging and pathology), treatment has been discussed for early breast cancer (EBC), locally advanced, and MBC. In-depth information on loco-regional and systemic therapy has been provided focusing on standard treatment protocols as well as scenarios where treatment can be de-escalated or escalated.
由于生活方式的改变和接触风险因素,印度城市地区乳腺癌的发病率正在迅速上升。晚期诊断以及年轻女性患乳腺癌是印度乳腺癌最令人担忧的问题。与癌症诊断相关的意识缺乏和社会禁忌使女性在寻求及时医疗建议时犹豫不决。由于几乎一半的女性在50岁之前患上乳腺癌,乳腺癌诊断给家庭带来了巨大的经济负担,并影响整个家庭。此外,难以获得、负担不起以及高额的自付费用使情况更加严峻。女性发现很难在离家较近的地方获得高质量的癌症护理,最终不得不长途跋涉去寻求治疗。与西方相比,癌症流行病学存在显著差异,这使得印度女性采用西方乳腺癌管理指南具有挑战性。在本文中,我们打算从中低收入国家的角度,对乳腺癌从诊断到早期和晚期治疗的管理进行全面综述。首先简要介绍流行病学和诊断方法(影像学和病理学)指南,然后讨论了早期乳腺癌(EBC)、局部晚期和转移性乳腺癌的治疗。针对局部区域和全身治疗提供了深入信息,重点关注标准治疗方案以及治疗可以降级或升级的情况。